Neoadjuvant sunitinib for surgically complex advanced renal cell cancer of doubtful resectability: initial experience with downsizing to reconsider cytoreductive surgery

Axel Bex; Astrid A. M. van der Veldt; Christian Blank; Alfons J. M. van den Eertwegh; Epie Boven; Simon Horenblas; John Haanen

首页> 外文期刊>World Journal of Urology >Neoadjuvant sunitinib for surgically complex advanced renal cell cancer of doubtful resectability: initial experience with downsizing to reconsider cytoreductive surgery

【24h】

Neoadjuvant sunitinib for surgically complex advanced renal cell cancer of doubtful resectability: initial experience with downsizing to reconsider cytoreductive surgery

机译：新辅助舒尼替尼用于可手术切除的复杂性晚期肾细胞癌：缩小规模以重新考虑减细胞手术的初步经验

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective To evaluate neoadjuvant sunitinib in patients with synchronous metastatic renal cell cancer (mRCC) to downsize surgically complex tumours and reconsider cytoreductive surgery.

机译：目的评估同步转移性肾细胞癌（mRCC）患者的新辅助舒尼替尼以缩小手术复杂性肿瘤的大小并重新考虑细胞减灭术。

著录项

来源
《World Journal of Urology》 |2009年第4期|p.533-539|共7页
作者
Axel Bex; Astrid A. M. van der Veldt; Christian Blank; Alfons J. M. van den Eertwegh; Epie Boven; Simon Horenblas; John Haanen;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Neoadjuvant sunitinib for surgically complex advanced renal cell cancer of doubtful resectability: initial experience with downsizing to reconsider cytoreductive surgery. [J] . Bex A, van der Veldt AA, Blank C World journal of urology . 2009,第4期

机译：新辅助舒尼替尼用于可手术切除性复杂的复杂晚期肾细胞癌：缩小规模以重新考虑减细胞手术的初步经验。
2. Cost effectiveness of neoadjuvant chemotherapy followed by interval cytoreductive surgery versus primary cytoreductive surgery for patients with advanced stage ovarian cancer during the initial treatment phase [J] . Tran Arthur-Quan, Erim Daniel O., Sullivan Stephanie A., Gynecologic Oncology: An International Journal . 2018,第2期

机译：Neoadjuvant化疗的成本有效性，然后是间隔细胞患者手术与初始治疗阶段晚期卵巢癌患者的初级细胞功能性手术
3. Neoadjuvant chemotherapy followed by interval cytoreductive surgery in patients with unresectable, advanced stage epithelial ovarian cancer: a single centre experience. [J] . Bilici A, Salepci T, Dane F, Archives of gynecology and obstetrics. . 2010,第4期

机译：对无法切除的晚期上皮性卵巢癌患者进行新辅助化疗，然后进行间隔细胞减灭术：单中心经验。
4. Localization and Classification of Cell Nuclei in Post-Neoadjuvant Breast Cancer Surgical Specimen Using Fully Convolutional Networks [C] . Rene Bidart, Mehrdad J. Gangeh, Mohammad Peikari, SPIE Medical Imaging Conference . 2018

机译：使用完全卷积网络对新辅助后乳腺癌手术标本中细胞核的定位和分类
5. Analysis of Oncologic Outcomes Associated with Anti-adhesion Sodium Hyaluronate-Carboxymethylcellulose Barrier Following Optimal or Complete Cytoreductive Surgery for Ovarian, Fallopian Tube, and Peritoneal Cancers. [D] . Krill, Lauren. 2014

机译：卵巢癌，输卵管癌和腹膜癌的最佳或完全细胞还原手术后，与抗粘连透明质酸钠-羧甲基纤维素屏障相关的肿瘤学结果分析。
6. Cost effectiveness of neoadjuvant chemotherapy followed by interval cytoreductive surgery versus primary cytoreductive surgery for patients with advanced stage ovarian cancer during the initial treatment phase [O] . Arthur-Quan Tran, Daniel O. Erim, Stephanie A. Sullivan, -1

机译：在初始治疗阶段晚期卵巢癌患者中新辅助化疗后进行间隔细胞减灭术与原发性细胞减灭术的成本效益
7. Cost effectiveness of neoadjuvant chemotherapy followed by interval cytoreductive surgery versus primary cytoreductive surgery for patients with advanced stage ovarian cancer during the initial treatment phase [O] . Arthur-Quan Tran, Daniel O. Erim, Stephanie A. Sullivan, 2018

机译：Neoadjuvant化疗的成本有效性随后是初始治疗阶段晚期卵巢癌患者的间隔细胞功能术治疗患者

Neoadjuvant sunitinib for surgically complex advanced renal cell cancer of doubtful resectability: initial experience with downsizing to reconsider cytoreductive surgery

摘要

著录项

相似文献

相关主题

期刊订阅